Actualités et Activités de Full-Life Technologies
Présence
Siège : Etats—Unis
Acquisition, funding and merger involving Full-Life Technologies.
- Full-Life Technologies vient d'annoncer une levée de fonds de 150 millions de dollars. (publié le 20 mai 2026).
Dirigeants
Voir l'organigramme avec ses 21 principaux dirigeants
Biographies les plus recherchées chez Full-Life Technologies
- Lanny Sun, Co-Founder, Chairman and Chief Executive Officer
- Gaopeng Chen, Director
- Trency Gu, Director
Créer une alerte
pour suivre les mouvements de dirigeants chez Full-Life Technologies.
Équipements médicaux
Full-Life Technologies a 1 235 concurrents dont Thermo Fisher Scientific (Etats—Unis), Medtronic (Irlande) et Philips (Pays—Bas).
Actualités en fusion/acquisition en Équipements médicaux.
- Niowave vient d'annoncer une levée de fonds de 70 millions de dollars. (publié le 2 juin 2026).
- Le nouveau nom de Edap Tms est FocalTherics. (publié le 1 juin 2026).
- FocalTherics est désormais coté en bourse sous le code FOCL. (publié le 31 mai 2026).
Contacts en Équipements médicaux
Actualités
Derniers communiqués de presse par Full-Life Technologies
- Full-Life Technologies to Participate in the 43rd Annual J.P. Morgan Healthcare Conference-Press Releases-From Half-Life to Full-Life.Full-Life Technologies to Participate in the 43rd Annual J.P. Morgan Healthcare Conference-Press Releases-From Half-Life
- Full-Life Technologies Announced the Progress of its Radioisotope Manufacturing Facility in Belgium-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announced the Progress of its Radioisotope Manufacturing Facility in Belgium-Press Releas
- Full-Life Technologies to Present Three Top Rated Oral Presentations at the 37th Annual Congress of the European Association of Nuclear Medicine-Press Releases-From Half-Life to Full-Life.Full-Life Technologies to Present Three Top Rated Oral Presentation
- Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors-Press Releases-Fro
- Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors-Press Releases-From Half-Life to Full-Life.Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Ther
- Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-
- Press Releases-From Half-Life to Full-Life.Press Releases-From Half-Life to Full-Life.
- Full-Life Technologies Announces Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announces Clearance from FDA of
- Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Disclosed Preclinical Data of its NTSR1-
- Full-Life Technologies will showcase preclinical data of its NTSR1-targeted RDC program FL-091 in an oral presentation at the 2024 SNMMI Annual Meeting-Press Releases-From Half-Life to Full-Life.Full-Life Technologies will showcase preclinical data of its
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Full-Life Technologies
- Full-Life Technologies sur Wikipédia, Google News & Yahoo Finance en 1-click
- Full-Life Technologies sur LinkedIn, X (Twitter) & YouTube en 1-click
